Brainsway Ltd. (BWAY)
16.55
-0.32
(-1.90%)
USD |
NASDAQ |
Dec 17, 10:09
Brainsway EPS Diluted (Quarterly): 0.0828 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Compugen Ltd. | -0.0746 |
| Can-Fite BioPharma Ltd. | -- |
| BiomX, Inc. | -5.546 |
| Nasus Pharma Ltd. | -- |
| Regentis Biomaterials Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.573M |
| Revenue (Quarterly) | 13.58M |
| Total Expenses (Quarterly) | 12.00M |
| Enterprise Value | 254.80M |
| Gross Profit Margin (Quarterly) | 75.18% |
| Profit Margin (Quarterly) | 11.59% |
| Earnings Yield | 1.90% |
| Operating Earnings Yield | 0.91% |